SK Biopharmaceuticals Co., Ltd. (326030.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 80,000.00

From 52W high−43.71%

Volume222785.00

Market capKRW 6.06T

P/E (TTM)16.0x

P/S (TTM)7.0x

Div yield—

Key dataSep 18, 2026

Open

KRW 80,000.00

From 52W high

−43.71%

Volume

222785.00

Market cap

KRW 6.06T

ValuationView details →

P/E (Fwd)

39.3x

EV/EBITDA

24.3x

P/E (TTM)

16.0x

RSI (14)

36.7

MomentumView details →

1D Return

+1.28%

YTD Return

−37.64%

ValuationView details →

P/E (Fwd)

39.3x

P/E (TTM)

16.0x

EV/EBITDA

24.3x

EV/Sales

6.6x

P/S (TTM)

7.0x

P/B (TTM)

5.9x

ProfitabilityView details →

Gross Margin

91.89%

Net Margin

46.55%

EBITDA Margin

27.40%

ROE (TTM)

39.24%

ROA (TTM)

28.26%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

+38.86%

EPS YoY

+51.58%

FCF YoY

+173.36%

Revenue CAGR 3Y

+42.12%

EPS CAGR 3Y

+11.14%

EBITDA YoY

+0.51%

MomentumView details →

1D Return

+1.28%

YTD Return

−37.64%

1Y Return

−31.54%

RSI (14)

36.7

vs 50D SMA

−5.99%

vs 200D SMA

−22.94%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

2.72x

Quick Ratio

2.42x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

KRW 581.55

EPS Surprise

3.17%

Beats (12Q)

1/12

Next Q EPS Est

KRW 594.78

Avg Surprise (4Q)

3.17%

Rev Surprise

5.80%

Financials snapshotView financials →

Revenue (TTM)

861.34B

Net Income (TTM)

400.96B

Op. CF (TTM)

251.61B

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for 326030.KS.

Similar companies

Samsung Epis Holdings0126Z0.KS HLB Co., Ltd.028300.KQ PharmaResearch Co., Ltd.214450.KQ Peptron, Inc.087010.KQ LigaChem Biosciences Inc.141080.KQ Hugel, Inc.145020.KQ Find similar companies →

Latest newsMore news →

No recent news for 326030.KS.